共 233 条
- [1] Dolati S(2017)Multiple sclerosis: therapeutic applications of advancing drug delivery systems Biomed Pharmacother 86 343-53
- [2] Babaloo Z(2012)Pathology of demyelinating diseases Annu Rev Pathol. 7 185-217
- [3] Jadidi-Niaragh F(2014)The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosis Mult Scler Int. 2014 285245-226
- [4] Ayromlou H(2021)The Ins and Outs of Central Nervous System Inflammation-Lessons Learned from Multiple Sclerosis Annu Rev Immunol. 39 199-901
- [5] Sadreddini S(2013)[Immunology for understanding the pathogenesis of multiple sclerosis] Rinsho Shinkeigaku 53 898-41
- [6] Yousefi M(2020)The role of TH17 cells in multiple sclerosis: therapeutic implications Autoimmun Rev. 19 102647-34
- [7] Popescu BF(2019)TLR4-RelA-miR-30a signal pathway regulates Th17 differentiation during experimental autoimmune encephalomyelitis development J Neuroinflammation 16 3329-8
- [8] Lucchinetti CF(2009)Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis Brain: J Neurol. 132 329-90
- [9] Duffy SS(2007)The function of interleukin 17 in the pathogenesis of rheumatoid arthritis Arch Immunol Ther Exp (Warsz.) 55 382-9
- [10] Lees JG(2018)Role of TFH Cells in Promoting T Helper 17-Induced Neuroinflammation Front Immunol. 9 88-44